Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic

Condition:   TuberculosisInterventions:   Drug: etoricoxib;   Biological: H56:IC31Sponsors:   Anne Margarita Dyrhol Riise;   University of Oslo;   Statens Serum InstitutNot yet recruiting - verified July 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials